Shmuel Chen, M.D., Ph.D.
Locations and Appointments
Please contact the doctor's office to verify that your insurance is accepted.
- Blue Access
- Blue Connection
- Mediblue (Senior)
- Medicare Advantage
- Community Plan
About Shmuel Chen, M.D., Ph.D.
Cardiovascular disease is a leading cause of morbidity and mortality in the United States. Specifically, coronary artery disease (i.e. blockages in the heart vessels) or structural heart disease (including valvular heart conditions) can result in significant symptoms, worsening heart function, and poor prognosis without treatment. While many of these conditions would previously require open-heart surgery, advances in the field of interventional cardiology have allowed for the development of transcatheter or percutaneous therapies which may allow for less invasive treatment options.
My focus is to help patients better understand their cardiovascular medical conditions and available treatment options for these problems. I aspire to provide tailored therapies and the most up-to-date and cutting-edge treatments for my patients. As I have dedicated my career to the diagnosis and treatment of cardiovascular disease, I am confident that better understanding of the nature of disease processes aided by forward thinking clinical research and early adoption of new technologies may help generate further information and knowledge to help provide the best care for my patients.
Dr. Shmuel Chen is an Assistant Professor of Medicine at Weill Cornell Medicine and the NewYork-Presbyterian Hospital. He specializes in interventional cardiology including the treatment of coronary and structural heart disease.
Dr. Chen received his medical degree from The Hebrew University School of Medicine (Jerusalem, Israel) as well as a PhD in Neurobiology from the Hebrew University School of Medicine. He completed his training in internal medicine and cardiology at the Hebrew University, Hadassah Medical Center (Jerusalem, Israel), where he also served as a Staff Cardiologist and a Lecturer in Cardiology. He subsequently moved to New York City and dedicated over 2 years to a prestigious research fellowship at the Cardiovascular Research Foundation (CRF). During this time, he worked towards designing and undertaking cutting-edge clinical trials and research in interventional cardiology. He has lead and extensively contributed to a number of projects and studies, exploring all aspects of cardiovascular and structural heart disease. These works have been published in leading medical journals in the field. After this focused research time, Dr. Chen joined The Columbia University Irving Medical Center and the NewYork-Presbyterian Hospital (New York, NY) for a two-year interventional cardiology fellowship program in July 2019. He gained specialty training in coronary interventions and strcutrual heart disease including aortic, mitral, tricuspid, paravalvular leak, patent foramen ovale (PFO), and left atrial appendage procedures. He joined the Weill Cornell Medical Center in September 2021 for another year of advanced structural heart training and served as an Instructor in Medicine.
2012 Hebrew University, School of Medicine, Faculty prize for "Distinction in Clinical Work"
2003 - 2007 Education program scholarship from the Hebrew University
2002 Dean’s award for excellence, Hebrew University
1999 Rector’s award for excellence, Hebrew University
1998 Dean’s award for excellence, Hebrew University
Ph.D.Hebrew University (Israel)2014
M.D.Hebrew University (Israel)2008
M.Sc.Hebrew University (Israel)2005
B.A.Hebrew University (Israel)2001
Assistant Attending PhysicianNewYork-Presbyterian Hospital
Assistant Professor of MedicineWeill Cornell Medical College, Cornell University
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.
No External Relationships Reported